pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Marketed
pancrelipase
Viokace (pancrelipase)
Exocrine Pancreatic Insufficiency
Allergan USA Inc
Marketed
pancrelipase DR
Pancreaze (pancrelipase)
Exocrine Pancreatic Insufficiency
Vivus LLC
Marketed
pancuronium bromide
Pancuronium Bromide
Muscle Relaxation
Dr. Reddy's Laboratories Ltd
Marketed
← prev
page 241 of 271
next →
Pain
89
Neurology
1
panitumumab
Vectibix (panitumumab)
Metastatic Colorectal Cancer
$AMGN
AMGEN INC
Phase 2
panobacumab
Aerumab (panobacumab [INN])
Hospital Acquired Pneumonia (HAP)
Aridis Pharmaceuticals Inc
Marketed
pantoprazole
Pantoprazole Sodium (pantoprazole)
Corrosive Esophagitis (Erosive Esophagitis)
Alembic Pharmaceuticals Inc
Marketed
pantoprazole sodium DR
Pantoprazole Sodium
Corrosive Esophagitis (Erosive Esophagitis)
Lifestar Pharma LLC
Marketed
pantoprazole sodium ER
Pantoprazole Sodium
Corrosive Esophagitis (Erosive Esophagitis)
$AMRX
Amneal Pharmaceuticals, Inc.
Marketed
parathyroid hormone
Natpara (parathyroid hormone)
Hypoparathyroidism
Takeda Pharmaceuticals America Inc
Marketed
paricalcitol
Paricalcitol
Secondary Hyperparathyroidism
Marksans Pharma Inc
Phase 3
paridiprubart
paridiprubart
Coronavirus Disease 2019 (COVID-19) Associated Acute Resp…
$EDSA
Edesa Biotech, Inc.
pre_registration
pariglasgene brecaparvovec
pariglasgene brecaparvovec
Glycogen Storage Disease 1A
$RARE
Ultragenyx Pharmaceutical Inc.
Phase 3
paromomycin
Paromomycin Sulfate (paromomycin [INN])
Leishmaniasis
Appili Therapeutics Inc
Marketed
paroxetine hydrochloride ER
Paroxetine Hydrochloride
Major Depressive Disorder
CPL Inc
Marketed
paroxetine mesylate
Brisdelle (paroxetine mesylate)
Vasomotor Symptoms of Menopause (Hot Flashes)
Legacy Pharma Solutions
Marketed
pasireotide
Signifor (pasireotide)
Pituitary ACTH Hypersecretion (Cushing Disease)
Recordati Corp
Marketed
pasireotide LA
Signifor LAR (pasireotide)
Acromegaly
Recordati Rare Diseases Inc
Phase 3
pasritamig
pasritamig
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$JNJ
JOHNSON & JOHNSON
Phase 3
patidegib hydrochloride
patidegib hydrochloride
Gorlin Syndrome (Basal Cell Nevus Syndrome/ Nevoid Basal…
$SLGL
Sol-Gel Technologies Ltd.
Marketed
patiromer sorbitex calcium
Veltassa (patiromer sorbitex calcium)
Hyperkalemia
Vifor Pharma Inc
Marketed
patisiran
Onpattro (patisiran)
Familial Amyloid Neuropathies
$ALNY
ALNYLAM PHARMACEUTICALS, INC.
Phase 3
patritumab deruxtecan
patritumab deruxtecan
Human Epidermal Growth Factor Receptor 2 Negative Breast…
Daiichi Sankyo Co Ltd
Phase 3
paxalisib
paxalisib
Recurrent Glioblastoma Multiforme (GBM)
$KZIA
KAZIA THERAPEUTICS LTD
Marketed
pazopanib hydrochloride
Pazopanib Hydrochloride
Renal Cell Carcinoma
Novugen Pharma (Malaysia) Sdn Bhd
Marketed
peanut (Arachis hypogaea) allergen
Palforzia
Peanut Allergy
Aimmune Therapeutics Inc
Phase 2
peceleganan
peceleganan [INN]
Diabetic Foot Ulcers
Jiangsu ProteLight Pharmaceutical And Biotechnology Co Ltd
pre_registration
pegargiminase
pegargiminase
Malignant Pleural Mesothelioma
$PII
Polaris Inc.
Marketed
pegaspargase
Oncaspar (pegaspargase)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…
Servier Pharmaceuticals LLC
Marketed
pegcetacoplan
Empaveli (pegcetacoplan)
Paroxysmal Nocturnal Hemoglobinuria
$APLS
Apellis Pharmaceuticals, Inc.
Phase 2
pegevongitide
pegevongitide [INN]
Coronavirus Disease 2019 (COVID-19) Pneumonia
Vasomune Therapeutics Inc